Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dendritic Cell Cancer Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dendritic Cell Cancer Vaccinemarket, defines the market attractiveness level of Dendritic Cell Cancer Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dendritic Cell Cancer Vaccine industry, describes the types of Dendritic Cell Cancer Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dendritic Cell Cancer Vaccine market and the development prospects and opportunities of Dendritic Cell Cancer Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dendritic Cell Cancer Vaccine market in Chapter 13.
By Player:
Northwest Biotherapeutics
Medigene
Elios Therapeutics
DCPrime
Creagene
Activarti
Batavia Bioservices
Tella
Glaxo Smith Kline
ImmunoCellular
Kiromic
DanDrit Biotech
Argos Therapeutics
Bellicum Pharmaceuticals
Vaxil Bio
Immunicum
Sanpower Corporation (Dendreon)
Merck
By Type:
CreaVax
Sipuleucel-T
Others
By End-User:
Pediatrics
Adults
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dendritic Cell Cancer Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dendritic Cell Cancer Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dendritic Cell Cancer Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dendritic Cell Cancer Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dendritic Cell Cancer Vaccine Market Analysis and Outlook to 2022
-
7.1 Global Dendritic Cell Cancer Vaccine Consumption (2017-2022)
-
7.2 United States Dendritic Cell Cancer Vaccine Consumption (2017-2022)
-
7.3 Europe Dendritic Cell Cancer Vaccine Consumption (2017-2022)
-
7.4 China Dendritic Cell Cancer Vaccine Consumption (2017-2022)
-
7.5 Japan Dendritic Cell Cancer Vaccine Consumption (2017-2022)
-
7.6 India Dendritic Cell Cancer Vaccine Consumption (2017-2022)
-
7.7 South Korea Dendritic Cell Cancer Vaccine Consumption (2017-2022)
8 Region and Country-wise Dendritic Cell Cancer Vaccine Market Analysis and Outlook to 2028
-
8.1 Global Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
-
8.2 United States Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
-
8.4 China Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
-
8.6 India Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea Dendritic Cell Cancer Vaccine Consumption Forecast (2022-2028)
9 Global Dendritic Cell Cancer Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global Dendritic Cell Cancer Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CreaVax Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sipuleucel-T Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Dendritic Cell Cancer Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pediatrics Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Adults Consumption and Growth Rate (2017-2022)
10 Global Dendritic Cell Cancer Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CreaVax Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Sipuleucel-T Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)
11 Global Dendritic Cell Cancer Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dendritic Cell Cancer Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dendritic Cell Cancer Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dendritic Cell Cancer Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dendritic Cell Cancer Vaccine Market Competitive Analysis
-
14.1 Northwest Biotherapeutics
-
14.1.1 Northwest Biotherapeutics Company Details
-
14.1.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product and Service
-
14.2 Medigene
-
14.2.1 Medigene Company Details
-
14.2.2 Medigene Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Medigene Dendritic Cell Cancer Vaccine Product and Service
-
14.3 Elios Therapeutics
-
14.3.1 Elios Therapeutics Company Details
-
14.3.2 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Product and Service
-
14.4 DCPrime
-
14.4.1 DCPrime Company Details
-
14.4.2 DCPrime Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 DCPrime Dendritic Cell Cancer Vaccine Product and Service
-
14.5 Creagene
-
14.5.1 Creagene Company Details
-
14.5.2 Creagene Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Creagene Dendritic Cell Cancer Vaccine Product and Service
-
14.6 Activarti
-
14.6.1 Activarti Company Details
-
14.6.2 Activarti Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Activarti Dendritic Cell Cancer Vaccine Product and Service
-
14.7 Batavia Bioservices
-
14.7.1 Batavia Bioservices Company Details
-
14.7.2 Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Batavia Bioservices Dendritic Cell Cancer Vaccine Product and Service
-
14.8 Tella
-
14.8.1 Tella Company Details
-
14.8.2 Tella Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Tella Dendritic Cell Cancer Vaccine Product and Service
-
14.9 Glaxo Smith Kline
-
14.9.1 Glaxo Smith Kline Company Details
-
14.9.2 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product and Service
-
14.10 ImmunoCellular
-
14.10.1 ImmunoCellular Company Details
-
14.10.2 ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 ImmunoCellular Dendritic Cell Cancer Vaccine Product and Service
-
14.11 Kiromic
-
14.11.1 Kiromic Company Details
-
14.11.2 Kiromic Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Kiromic Dendritic Cell Cancer Vaccine Product and Service
-
14.12 DanDrit Biotech
-
14.12.1 DanDrit Biotech Company Details
-
14.12.2 DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 DanDrit Biotech Dendritic Cell Cancer Vaccine Product and Service
-
14.13 Argos Therapeutics
-
14.13.1 Argos Therapeutics Company Details
-
14.13.2 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Product and Service
-
14.14 Bellicum Pharmaceuticals
-
14.14.1 Bellicum Pharmaceuticals Company Details
-
14.14.2 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product and Service
-
14.15 Vaxil Bio
-
14.15.1 Vaxil Bio Company Details
-
14.15.2 Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Vaxil Bio Dendritic Cell Cancer Vaccine Product and Service
-
14.16 Immunicum
-
14.16.1 Immunicum Company Details
-
14.16.2 Immunicum Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Immunicum Dendritic Cell Cancer Vaccine Product and Service
-
14.17 Sanpower Corporation (Dendreon)
-
14.17.1 Sanpower Corporation (Dendreon) Company Details
-
14.17.2 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Product and Service
-
14.18 Merck
-
14.18.1 Merck Company Details
-
14.18.2 Merck Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Merck Dendritic Cell Cancer Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dendritic Cell Cancer Vaccine
-
Figure Dendritic Cell Cancer Vaccine Picture
-
Table Global Dendritic Cell Cancer Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dendritic Cell Cancer Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dendritic Cell Cancer Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dendritic Cell Cancer Vaccine Consumption by Country (2017-2022)
-
Figure United States Dendritic Cell Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe Dendritic Cell Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China Dendritic Cell Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan Dendritic Cell Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India Dendritic Cell Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dendritic Cell Cancer Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Dendritic Cell Cancer Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dendritic Cell Cancer Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CreaVax Consumption and Growth Rate (2017-2022)
-
Figure Global Sipuleucel-T Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatrics Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global CreaVax Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sipuleucel-T Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatrics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dendritic Cell Cancer Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dendritic Cell Cancer Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table Northwest Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product and Service
-
Table Medigene (Foundation Year, Company Profile and etc.)
-
Table Medigene Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medigene Dendritic Cell Cancer Vaccine Product and Service
-
Table Elios Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Elios Therapeutics Dendritic Cell Cancer Vaccine Product and Service
-
Table DCPrime (Foundation Year, Company Profile and etc.)
-
Table DCPrime Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table DCPrime Dendritic Cell Cancer Vaccine Product and Service
-
Table Creagene (Foundation Year, Company Profile and etc.)
-
Table Creagene Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Creagene Dendritic Cell Cancer Vaccine Product and Service
-
Table Activarti (Foundation Year, Company Profile and etc.)
-
Table Activarti Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Activarti Dendritic Cell Cancer Vaccine Product and Service
-
Table Batavia Bioservices (Foundation Year, Company Profile and etc.)
-
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Product and Service
-
Table Tella (Foundation Year, Company Profile and etc.)
-
Table Tella Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tella Dendritic Cell Cancer Vaccine Product and Service
-
Table Glaxo Smith Kline (Foundation Year, Company Profile and etc.)
-
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glaxo Smith Kline Dendritic Cell Cancer Vaccine Product and Service
-
Table ImmunoCellular (Foundation Year, Company Profile and etc.)
-
Table ImmunoCellular Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoCellular Dendritic Cell Cancer Vaccine Product and Service
-
Table Kiromic (Foundation Year, Company Profile and etc.)
-
Table Kiromic Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kiromic Dendritic Cell Cancer Vaccine Product and Service
-
Table DanDrit Biotech (Foundation Year, Company Profile and etc.)
-
Table DanDrit Biotech Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table DanDrit Biotech Dendritic Cell Cancer Vaccine Product and Service
-
Table Argos Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argos Therapeutics Dendritic Cell Cancer Vaccine Product and Service
-
Table Bellicum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product and Service
-
Table Vaxil Bio (Foundation Year, Company Profile and etc.)
-
Table Vaxil Bio Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vaxil Bio Dendritic Cell Cancer Vaccine Product and Service
-
Table Immunicum (Foundation Year, Company Profile and etc.)
-
Table Immunicum Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunicum Dendritic Cell Cancer Vaccine Product and Service
-
Table Sanpower Corporation (Dendreon) (Foundation Year, Company Profile and etc.)
-
Table Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Dendritic Cell Cancer Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Dendritic Cell Cancer Vaccine Product and Service
-
